Company Details
abbvie
58,020
1,735,135
3254
abbvie.com
571
ABB_1856359
Completed

AbbVie Company CyberSecurity Posture
abbvie.comAbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
Company Details
abbvie
58,020
1,735,135
3254
abbvie.com
571
ABB_1856359
Completed
Between 800 and 849

AbbVie Global Score (TPRM)XXXX

Description: The industrial behemoths Schneider Electric, werum.com, UCLA (http://ucla.edu), Abbie (http://abbvie.com), and Siemens Energy are among the five new MOVEit attacks victims listed on the dark web leak site for the Clop ransomware organization. Industrial Control Systems (ICS) are offered by Siemens Energy and Schneider Electric and are employed in crucial national infrastructures all over the world. Threat actors assert that by using the recently discovered MOVEit Transfer vulnerability CVE-2023-34362, they were able to breach 100 different businesses. Incentives are provided by the US government for intelligence that results in the capture, indictment, or location of threat actors.


No incidents recorded for AbbVie in 2025.
No incidents recorded for AbbVie in 2025.
No incidents recorded for AbbVie in 2025.
AbbVie cyber incidents detection timeline including parent company and subsidiaries

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

CVS Pharmacy is America’s leading retail pharmacy with more than 9,600 locations nationwide. For more than 50 years, CVS Pharmacy has offered customers the products and services they need to stay on their path to better health. In addition to our pharmacies, our stores feature on-trend beauty depart

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitm

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing,

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working t

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching t

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portf

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread acro
For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists
.png)
Close-up of a laptop as AI News caught up with Rachel James, Principal. Share this story:.
Cencora, The Lash Group, and their affiliates have agreed to pay $40 million to settle class action data breach litigation over a February...
Over the past twelve months, AbbVie generated $56 billion in revenue, achieving an operating profit of $12 billion and a net income of $4.3...
The US Supreme Court is poised to provide important guidance on the PSLRA's particularity requirement in NVIDIA Corp. v. E. Ohman J:or Fonder AB, Case No. 23-...
ORMOND BEACH, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Health Information Sharing and Analysis Center (Health-ISAC), the non-profit...
Health-ISAC announces results of Board elections, reaffirming its role as a trusted global community for sharing cyber and physical security...
We believe that AbbVie stock (NYSE: ABBV) is currently a better pharmaceutical pick over Johnson & Johnson stock (NYSE: JNJ).
Fenwick is representing Aliada Therapeutics, a biotechnology company advancing therapies using a novel blood-brain barrier (BBB)-crossing technology.
The Golden Ticket Pitch Competition, offered by the American Cancer Society's BrightEdge in collaboration with AbbVie and Research Bridge...

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of AbbVie is http://www.abbvie.com.
According to Rankiteo, AbbVie’s AI-generated cybersecurity score is 826, reflecting their Good security posture.
According to Rankiteo, AbbVie currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, AbbVie is not certified under SOC 2 Type 1.
According to Rankiteo, AbbVie does not hold a SOC 2 Type 2 certification.
According to Rankiteo, AbbVie is not listed as GDPR compliant.
According to Rankiteo, AbbVie does not currently maintain PCI DSS compliance.
According to Rankiteo, AbbVie is not compliant with HIPAA regulations.
According to Rankiteo,AbbVie is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
AbbVie operates primarily in the Pharmaceutical Manufacturing industry.
AbbVie employs approximately 58,020 people worldwide.
AbbVie presently has no subsidiaries across any sectors.
AbbVie’s official LinkedIn profile has approximately 1,735,135 followers.
AbbVie is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Yes, AbbVie has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/abbvie.
Yes, AbbVie maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/abbvie.
As of December 11, 2025, Rankiteo reports that AbbVie has experienced 1 cybersecurity incidents.
AbbVie has an estimated 5,412 peer or competitor companies worldwide.
Incident Types: The types of cybersecurity incidents that have occurred include Breach.
Detection and Response: The company detects and responds to cybersecurity incidents through an law enforcement notified with us government incentives for intelligence..
Title: MOVEit Transfer Vulnerability Exploited by Clop Ransomware
Description: The Clop ransomware organization has listed five new victims of MOVEit attacks on the dark web, including Schneider Electric, werum.com, UCLA, Abbie, and Siemens Energy. The threat actors claim to have breached 100 different businesses using the recently discovered MOVEit Transfer vulnerability CVE-2023-34362.
Type: Ransomware
Attack Vector: Exploitation of Vulnerability
Vulnerability Exploited: CVE-2023-34362
Threat Actor: Clop ransomware organization
Motivation: Financial gain
Common Attack Types: The most common types of attacks the company has faced is Breach.

Entity Name: Schneider Electric
Entity Type: Company
Industry: Industrial Control Systems
Location: Global

Entity Name: UCLA
Entity Type: Educational Institution
Industry: Education
Location: Los Angeles, CA

Entity Name: Siemens Energy
Entity Type: Company
Industry: Industrial Control Systems
Location: Global

Law Enforcement Notified: US government incentives for intelligence

Ransomware Strain: Clop
Additional Resources: Stakeholders can find additional resources on cybersecurity best practices at and Source: UCLAUrl: http://ucla.edu, and Source: AbbieUrl: http://abbvie.com.
Last Attacking Group: The attacking group in the last incident was an Clop ransomware organization.
Most Recent Source: The most recent source of information about an incident are Abbie and UCLA.
Most Recent URL for Additional Resources: The most recent URL for additional resources on cybersecurity best practices is http://ucla.edu, http://abbvie.com .
.png)
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
